YX0798
Product Specifications
Target
Apoptosis, c-Myc, Bcl-2 Family, CDK
Related Pathways
Apoptosis, Cell Cycle/Checkpoint
Bioactivity
YX0798 is a selective, orally active CDK9 inhibitor (Kd: 0.28 nM) . It downregulates the oncogenic protein c-MYC and the pro-survival protein MCL-1. YX0798 disrupts the cell cycle and causes transcriptome reprogramming, ultimately leading to apoptosis. The compound exhibits antitumor activity.
Smiles
ClC(C=NC(NC([C@H]1CCC[C@@H](NC(C(F)(F)F)=O)C1)=O)=C2)=C2C3=C4C(NC=C4)=NC=C3
Molecular Formula
C21H19ClF3N5O2
Molecular Weight
465.86
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx178545-01 200 µg
TEK Tyrosine Kinase, Endothelial (Tie2) Antibody
Sign In for Pricing
View Details 
137932-ML405 100 µL
ELOVL7 (Elongation of Very Long Chain Fatty Acids Protein 7, 3-keto Acyl-CoA Synthase ELOVL7, ELOVL Fatty Acid Elongase 7, ELOVL FA Elongase 7, Very-long-chain 3-oxoacyl-CoA Synthase 7, FLJ23563) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
LV786957 1.0 µg DNA
TFAMP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details